Intego ONE delivers excellent malware protection, fast scans, and strong firewall controls for Mac users, but some missing ...

City Council is set to discuss two new fees to help fund its Bureau of Transportation (PBOT) and critical street maintenance this week.

MONTREAL --Fans arrived at the Montreal Forum on March 10, 1955, hoping for an offensive slugfest between the Canadiens and visiting Toronto Maple Leafs, a ferocious rivalry steeped in bitterness.

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...

Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...

Add Popular Science (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Get the Popular ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Are you hearing that squeal or feeling that vibration when you press on the brake? Then you're probably in one of two camps — either you're a little tight on cash right now and you're hoping you can ...

Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...

If your PC is running slowly or has disk errors you need to address the problem. Rather than trying to uninstall programs you could run a scan on your hard drive to fix any errors. Here’s how to do ...

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...